GW Pharmaceuticals PLC Director/PDMR Shareholding (4730S)
01 December 2012 - 1:54AM
UK Regulatory
TIDMGWP
RNS Number : 4730S
GW Pharmaceuticals PLC
30 November 2012
GW Pharmaceuticals PLC Director/PDMR Shareholding
GW Pharmaceuticals PLC
30 November 2012
GW Pharmaceuticals PLC
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the
"Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 30 November 2012: GW Pharmaceuticals (AIM: GWP)
hereby provides notification that the Company was today notified
that Dr Geoffrey Guy, a Director and Executive Chairman of the
Company, transferred 21,600 0.1 pence ordinary shares of GW
Pharmaceuticals plc into his personal pension scheme.
This transaction, representing less than 0.1% of the Company's
current issued share capital, was completed when the market price
was 62.5 pence per share.
Following this notification Dr Guy's beneficial interest in
17,187,654 GW Pharmaceuticals plc ordinary shares of 0.1 pence
each, representing 12.9% of the Company's current issued share
capital, remains unchanged.
The total number of shares outstanding in the Company is
133,370,354 ordinary shares of 0.1 pence each.
Enquiries:
GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Adviser) Tel: +44 (0)207 418 8900
James Steel/Vijay Barathan
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFESLILIVIF
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles